Hepatitis B Foundation names Baruch S. Blumberg Prize winner

The Hepatitis B Foundation has awarded Stephen Urban, PhD, the 2023 Baruch S. Blumberg Prize for his development of bulevirtide, the first drug approved for the treatment of hepatitis D.“The entire hepatitis B/D community owes a tremendous debt to Dr. Urban for his conception, design and creation of new therapeutics for hepatitis B and D, as well as for his pioneering work on basic science advances toward understanding HBV and HDV virology,” Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, told Healio.Approved by the European Commission in July 2020, Urban, theRead More